欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Proteasome/Ubiquitin-Heat Shock Protein (HSP)-Debio 0932
Debio 0932

Chemical Structure : Debio 0932

CAS No.: 1061318-81-7

Debio 0932 (CUDC-305, RGRN-305)

货号: PC-49868Not For Human Use, Lab Use Only.

Debio 0932 (CUDC-305, RGRN-305) is a highly potent, oral and BBB-penetrant HSP90 inhibitor, shows high affinity for HSP90alpha/beta and HSP90 complex derived from cancer cells with IC50 of 100 nM and 48.8 nM, respectively.

规格 价格 库存 数量
5 mg ¥1280 In stock
10 mg ¥1880 In stock
25 mg ¥2780 In stock
50 mg ¥4780 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Debio 0932 (CUDC-305, RGRN-305) is a highly potent, oral and BBB-penetrant HSP90 inhibitor, shows high affinity for HSP90alpha/beta and HSP90 complex derived from cancer cells with IC50 of 100 nM and 48.8 nM, respectively.
Debio 0932 (CUDC-305) displays potent antiproliferative activity against a broad range of cancer cell lines with mean IC50 of 220 nM.
Debio 0932 (CUDC-305) exhibits dose-dependent antitumor activity in an s.c. xenograft model of U87MG glioblastoma and significantly prolongs animal survival in U87MG orthotopic model.
Debio 0932 (CUDC-305) also displays potent antitumor activity in animal models of erlotinib-resistant non-small cell lung cancer and induces tumor regression in animal models of MDA-MB-468 breast cancer and MV4-11 acute myelogenous leukemia.
Debio 0932 (CUDC-305) binds strongly to HSP90 extracted from erlotinib-resistant NSCLC cells (IC50=70 nM).
Debio 0932 (CUDC-305) potently inhibits tumor growth in subcutaneous xenograft models of H1975 and A549, which harbor EGFR T790M mutation or K-ras mutations conferring acquired and primary erlotinib resistance, respectively.

物理化学性质&存储条件

分子量 442.58
分子式 C22H30N6O2S
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-((6-(dimethylamino)benzo[d][1,3]dioxol-5-yl)thio)-1-(2-(neopentylamino)ethyl)-1H-imidazo[4,5-c]pyridin-4-amine

参考文献

1. Bao R, et al. Clin Cancer Res. 2009 Jun 15;15(12):4046-57.

2. Bao R, et al. Mol Cancer Ther. 2009 Dec;8(12):3296-306.

3. Isambert N, et al. Ann Oncol. 2015 May;26(5):1005-1011.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: